Neuroblastoma Treatment Market - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015- 2021

Report Code: ZMR-18 | Report Format : | Status : Upcoming |

Abstract

Neuroblastoma (NB) is the most common cancer in childhood and infancy. Neuroblastoma is a cancer that starts in primitive nerve cells. It rarely occurs after age around 10 years. Neuroblastoma is sometimes caused by a gene mutation passed from the parent to the child. It commonly start in the adrenal glands, it usually grows into a large, firm mass that presses other organs. It can also develop in nerves near the backbone and in the spinal cord, neck, chest, or abdomen. Some of the most common symptoms of the neuroblastoma are firm mass in the abdomen, enlarged stomach, weight, anemia, crankiness, fever, bone pain, bulging eyes, dark circles around the eyes, weakness, and high blood pressure.

A range of therapeutics or drugs has been adopted to treat the metastatic neuroblastoma such as immunotherapy, and chemotherapy. The neuroblastoma treatment market is mainly driven by the rising incidences of cancer worldwide. Growing healthcare expenses is another key factor to drive the neuroblastoma market. However, some issues like high cost treatment is expected to hamper growth of neuroblastoma treatment market. U.S. shows incidence of around 650 cases every year. Combination chemotherapy and ch14.18 monoclonal antibody therapy,vaccine therapy, lenalidomide and ch14.18 monoclonal antibody therapy with or without isotretinoin are some the treatments in clinical trials for neuroblastoma.

The report covers forecast and analysis for the neuroblastoma treatment market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million). The report also offers detailed competitive landscape of the global neuroblastoma treatment market. It includes company market share analysis, product portfolio of the major industry participants. The report provides detailed segmentation of the neuroblastoma treatment market based on region segment. Major regional segments analyzed in this study include North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. 

The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. Key players profiled in the report include Seattle Children’s, CureSearch, Texas Children’s, NANT and other.

This report segments the global neuroblastoma treatment market as follows:

Global Neuroblastoma Treatment Market: Regional Segment Analysis

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Related Reports

neurosimulation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-804 | Report Format:

neurosimulation Market: Overview The treatment of various illnesses such as incontinence, epilepsy, essential tremors, gastroparesis, Parkinsons disease and depression use neurosimulation. Neurosimulation is a high potential treatment in which the patients find relief from their pain, which is not...Read More

Portable Medical Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-785 | Report Format:

Global Portable Medical Devices Market: Overview Portable medical devices comprise curative and diagnostic medical devices are smaller and easy to handle without facing any inconveniences. Recently, the healthcare sector has evolved on a large scale owing to miniaturization of the medical compon...Read More

Hyperspectral Imaging System Market by Component type (Hyperspectral Cameras and Accessories) and by Application type (Military Surveillance, Remote Sensing, Life Sciences & Medical Diagnostics, Machine Vision/Optical Sorting and Other) - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2016 - 2022

Jan-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-766 | Report Format:

The report covers forecast and analysis for the hyperspectral imaging system market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based on revenue (USD Billion). The study includes drivers and restraints for the hyperspectral imagi...Read More

Surgical Imaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-756 | Report Format:

Global Surgical Imaging Market: Overview Surgical imaging is a profound optical imaging technique that is used in image-guided surgical processes. The technique allows the clinicians to accomplish intricate surgical procedures precisely. Surgical imaging uses computed tomography scanners, C-arms...Read More

Revenue Cycle Management Market by Product (Integrated and Standalone) by Component (Services and Software) and by Deployment (Web-Based On-Premise and Cloud-Based Systems) For Physician, Hospitals, Medical and Diagnostic Laboratories, and Others - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2016 - 2022

Jan-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-683 | Report Format:

The report covers forecast and analysis for the revenue cycle management market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2016 to 2022 based on revenue (USD Billion). The study includes drivers and restraints for the revenue cycle managemen...Read More

Choose License Type: